Finding the right people focused on rare diseases is not straightforward and can require resource-constrained teams to prioritize just a handful of experts. Malcolm Crooks, one of the industry’s leading innovators and the COO of COUR Pharmaceuticals discusses the challenges in finding the right people to engage with and turning that into treatments for patients.

More Customer Stories

Delivering for the Five in 10,000 Patients Living With a Rare Disease
Read Perspectives on Rare Disease
ANI Pharmaceuticals: Launching With Speed and Scale
Watch the Webinar
Turning Point Therapeutics: Preparing for Launch With Commercial Content
Prepare Content for Launch

Interested in learning more about Veeva?